722 related articles for article (PubMed ID: 9933474)
1. Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat.
Lane NE; Haupt D; Kimmel DB; Modin G; Kinney JH
J Bone Miner Res; 1999 Feb; 14(2):206-14. PubMed ID: 9933474
[TBL] [Abstract][Full Text] [Related]
2. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
[TBL] [Abstract][Full Text] [Related]
3. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
Lane NE; Thompson JM; Strewler GJ; Kinney JH
J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
[TBL] [Abstract][Full Text] [Related]
4. Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats.
Mawatari T; Miura H; Higaki H; Moro-Oka T; Kurata K; Murakami T; Iwamoto Y
J Bone Miner Res; 2000 Sep; 15(9):1810-7. PubMed ID: 10977000
[TBL] [Abstract][Full Text] [Related]
5. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis.
Deyhim F; Stoecker BJ; Brusewitz GH; Devareddy L; Arjmandi BH
Menopause; 2005; 12(6):755-62. PubMed ID: 16278620
[TBL] [Abstract][Full Text] [Related]
6. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
7. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.
Lane NE; Kimmel DB; Nilsson MH; Cohen FE; Newton S; Nissenson RA; Strewler GJ
J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776
[TBL] [Abstract][Full Text] [Related]
8. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
9. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
10. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
Iwaniec UT; Yuan D; Power RA; Wronski TJ
J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
Cui L; Wu T; Liu YY; Deng YF; Ai CM; Chen HQ
Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
[TBL] [Abstract][Full Text] [Related]
12. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model.
Lane NE; Kumer J; Yao W; Breunig T; Wronski T; Modin G; Kinney JH
Osteoporos Int; 2003 Jun; 14(5):374-82. PubMed ID: 12768279
[TBL] [Abstract][Full Text] [Related]
14. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
15. Microcracks: an alternative index for evaluating bone biomechanical quality.
Dai RC; Liao EY; Yang C; Wu XP; Jiang Y
J Bone Miner Metab; 2004; 22(3):215-23. PubMed ID: 15108063
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
Rhee Y; Won YY; Baek MH; Lim SK
J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
[TBL] [Abstract][Full Text] [Related]
17. Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys.
Ham KD; Carlson CS
J Bone Miner Res; 2004 May; 19(5):823-9. PubMed ID: 15068506
[TBL] [Abstract][Full Text] [Related]
18. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
Marie PJ; Hott M; Modrowski D; De Pollak C; Guillemain J; Deloffre P; Tsouderos Y
J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
[TBL] [Abstract][Full Text] [Related]
19. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.
Dalle Carbonare L; Arlot ME; Chavassieux PM; Roux JP; Portero NR; Meunier PJ
J Bone Miner Res; 2001 Jan; 16(1):97-103. PubMed ID: 11149495
[TBL] [Abstract][Full Text] [Related]
20. Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
Borah B; Dufresne TE; Chmielewski PA; Johnson TD; Chines A; Manhart MD
Bone; 2004 Apr; 34(4):736-46. PubMed ID: 15050906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
